Vertex has reached a key moment because the U.S. Food and Drug Administration (FDA) is reviewing its candidate, suzetrigine, ...
We are thrilled to announce that Recursion is setting a new gold standard for the industry with the release of ...
Attend Pittcon 2025 in Boston to connect with global leaders in laboratory science and explore cutting-edge advancements in ...
Investor's Business Daily on MSN7d
Vertex Flashes A Surprise Buy Point As Non-Opioid Pain Drug LoomsVertex Pharmaceuticals beat Wall Street's third-quarter expectations, but the real story for Vertex stock is still to come, analysts said Tuesday.Please watch the video at Investors.com - How To Buy ...
Phil Nadeau, an analyst from TD Cowen, maintained the Buy rating on Vertex Pharmaceuticals (VRTX – Research Report). The associated price ...
Vertex Pharmaceuticals Inc. (VRTX) on Monday reported third-quarter net income of $1.05 billion. On a per-share basis, the Boston-based company said it had net income of $4.
Premier Tax and Technology Conference Connects Industry Leaders, Showcases AI Capabilities KING OF PRUSSIA, Pa., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX) ("Vertex” or the "Company” ...
Shares of Vertex Pharmaceuticals Inc. VRTX slipped 1.26% to $470.36 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.16% ...
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in two upcoming investor conferences. Dr. Reshma Kewalramani, Chief Executive ...
In a corner at Ikea Tampines, the grey concrete floor becomes artist Vijaya Mohan’s canvas. With the help of co-artist Nithiya Ramprasad, 42, Vijaya lays a pre-cut blue plastic sheet measuring ...
Genomics, Inc. , a leader in single cell and spatial biology, today reported financial results for the third quarter ended September 30, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback